Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.482, 2005-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Appropriate diagnosis appears to improve therapy in CHF
Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. :
Updated guidelines for diagnosis, treatment of CHF from ESC
Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. :
BNP-guided CHF therapy seems a smart option
Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. :
Tolvaptan: advantages over standard therapy in CHF
Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. :